Selected article for: "high estimate and program date start"
Author: Worden, Lee; Wannier, Rae; Hoff, Nicole A.; Musene, Kamy; Selo, Bernice; Mossoko, Mathias; Okitolonda-Wemakoy, Emile; Muyembe Tamfum, Jean Jacques; Rutherford, George W.; Lietman, Thomas M.; Rimoin, Anne W.; Porco, Travis C.; Kelly, J. Daniel
Title: Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019
  • Document date: 2019_8_5
    • ID: 1lg2203q_24
    Snippet: To model vaccination coverage with respect to total transmission (unreported and reported), we multiplied the estimate of vaccine effectiveness by low and high estimates of reported cases. In a ring vaccination study at the end of the West Africa outbreak, the overall estimated recombinant vesicular stomatitis virus (rVSV)-vectored vaccine efficacy was 100% and vaccine effectiveness was 64.6% in protecting all contacts and contacts of contacts fr.....
    Document: To model vaccination coverage with respect to total transmission (unreported and reported), we multiplied the estimate of vaccine effectiveness by low and high estimates of reported cases. In a ring vaccination study at the end of the West Africa outbreak, the overall estimated recombinant vesicular stomatitis virus (rVSV)-vectored vaccine efficacy was 100% and vaccine effectiveness was 64.6% in protecting all contacts and contacts of contacts from EVD in the randomized clusters, including unvaccinated cluster members [36] . We used an estimate of 64.6% vaccine effectiveness in our stochastic model. The ring vaccination study found the vaccine to be effective against cases with onset dates 10 days or more from the date of vaccine administration, so we modeled the vaccination program as a proportionate reduction in the number of new cases with onsets 10 days or more after the program start date.

    Search related documents:
    Co phrase search for related documents
    • contact contact and onset date: 1, 2, 3, 4, 5, 6
    • contact contact and onset date case: 1, 2, 3, 4
    • contact contact and report case: 1, 2
    • contact contact and ring vaccination: 1
    • date start and high low estimate: 1, 2
    • date start and new case: 1
    • date start and onset date: 1, 2, 3, 4, 5
    • date start and program date start: 1, 2, 3
    • date start and proportionate reduction: 1
    • date start and randomized cluster: 1
    • date start and report case: 1, 2, 3
    • date start and ring vaccination: 1
    • date start and ring vaccination study: 1
    • EVD contact and new case: 1
    • high low estimate and onset date: 1
    • high low estimate and program date start: 1
    • high low estimate and proportionate reduction: 1
    • high low estimate and ring vaccination: 1
    • new case and report case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25